Cytotoxic triplets plus a biologic: state-of-the-art in maximizing the potential of up-front medical treatment of metastatic colorectal cancer

Author： Loupakis Fotios   Cremolini Chiara   Schirripa Marta   Masi Gianluca   Falcone Alfredo  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.4, 2011-04, pp. : 519-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High expression of Fatty Acid‐Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells

By  

FEBS Open Bio, Vol. 6, Iss. 3, 2016-02 ,pp. : 190-199

John Wiley & Sons Inc

Access to resources Recommend Favorite

How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?

By Bronte Giuseppe   Rolfo Christian   Peeters Marc   Russo Antonio  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of colorectal cancer

By Mulcahy Mary F   Benson III Al B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in the treatment of patients with colorectal cancer

By Garrett Christopher R   Eng Cathy  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 937-949

Informa Healthcare

Access to resources Recommend Favorite

Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy

By Bruera Gemma   Ricevuto Enrico  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 821-824

Informa Healthcare

Access to resources Recommend Favorite